| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
115,717,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,565,825 |
Avg
Vol: |
726,369 |
| 52
Week Range: |
$2.39 - $2.39 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lindsay Ronald M |
Exec VP, R&D |
• • – |
2012-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
9,001 |
67,602 |
|
- |
|
| Hixson Harry F Jr |
CEO |
• • – |
2012-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,501 |
98,194 |
|
- |
|
| Neumann Clarke |
VP & General Counsel |
• – – |
2012-02-07 |
4 |
D |
$4.92 |
$4,320 |
D/D |
(878) |
19,907 |
|
- |
|
| Neumann Clarke |
VP & General Counsel |
• – – |
2012-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,101 |
20,005 |
|
- |
|
| Monko Alexander Michael |
Sr VP, Sales & Marketing |
• – – |
2012-02-07 |
4 |
D |
$4.92 |
$5,407 |
D/D |
(1,099) |
28,613 |
|
- |
|
| Monko Alexander Michael |
Sr VP, Sales & Marketing |
• – – |
2012-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,626 |
28,736 |
|
- |
|
| Maier Paul V |
Chief Financial Officer |
• – – |
2012-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,001 |
53,111 |
|
- |
|
| Judge Alisa |
VP Human Resources |
• – – |
2012-02-07 |
4 |
D |
$4.92 |
$4,320 |
D/D |
(878) |
3,396 |
|
- |
|
| Judge Alisa |
VP Human Resources |
• – – |
2012-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,101 |
3,494 |
|
- |
|
| Pendarvis David |
Director |
– • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,056 |
20,348 |
|
- |
|
| Lerner Richard A |
Director |
– • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,924 |
5,924 |
|
- |
|
| Bombard Allan |
Chief Medical Officer |
• – – |
2011-12-12 |
4 |
B |
$3.93 |
$27,510 |
D/D |
7,000 |
26,892 |
2.74 |
- |
|
| Fazio John A |
Director |
– • – |
2011-12-06 |
4 |
B |
$4.00 |
$6,000 |
D/D |
1,500 |
19,219 |
2.39 |
- |
|
| Fazio John A |
Director |
– • – |
2011-11-21 |
4 |
B |
$4.00 |
$6,000 |
D/D |
1,500 |
17,719 |
2.39 |
- |
|
| Hixson Harry F Jr |
CEO |
• • – |
2011-11-16 |
4 |
B |
$4.19 |
$209,400 |
D/D |
50,000 |
72,354 |
2.81 |
- |
|
| Slacik Charles P |
Director |
– • – |
2011-11-15 |
4 |
B |
$4.10 |
$20,500 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| Buechler Kenneth F |
Director |
– • – |
2011-11-11 |
4 |
B |
$4.12 |
$50,082 |
D/D |
12,150 |
30,000 |
2.39 |
- |
|
| Lindsay Ronald M |
Exec VP, R&D |
• • – |
2011-11-07 |
4 |
B |
$4.23 |
$84,712 |
D/D |
20,000 |
57,950 |
2.81 |
- |
|
| Maier Paul V |
Chief Financial Officer |
• – – |
2011-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
51,110 |
|
- |
|
| Bombard Allan |
Chief Medical Officer |
• – – |
2011-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,944 |
19,892 |
|
- |
|
| Cantor Charles R |
Chief Scientific Officer |
• – – |
2011-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,166 |
2,508 |
|
- |
|
| Welch William J |
Sr. VP, Diagnostics |
• – – |
2011-07-18 |
4 |
D |
$7.46 |
$3,984 |
D/D |
(534) |
924 |
|
- |
|
| Welch William J |
Sr. VP, Diagnostics |
• – – |
2011-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,458 |
1,458 |
|
- |
|
| Hixson Harry F Jr |
CEO |
• • – |
2011-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
12,498 |
20,303 |
|
- |
|
| Monko Alexander Michael |
Sr VP, Sales & Marketing |
• – – |
2011-07-18 |
4 |
D |
$7.46 |
$3,984 |
D/D |
(534) |
27,086 |
|
- |
|
376 Records found
|
|
Page 7 of 16 |
|
|
